Corpus Intelligence IC Memo — MONROE CLINIC 2026-04-26 03:50 UTC
IC Memo — MONROE CLINIC
Investment Committee Memorandum | WI | 58 beds | Grade B | EBITDA uplift $14.4M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MONROE CLINIC

CCN 520028 | GREEN, WI | 58 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

MONROE CLINIC is a 58-bed suburban community hospital in GREEN, WI with $195.3M in net patient revenue and a -4.4% operating margin. The hospital serves a payer mix of 35.7% Medicare, 4.8% Medicaid, and 59.5% commercial.

Thesis: Turnaround. Our ML models identify $14.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -4.4% to 3.0% (+736bps).

Net Revenue HCRIS$195.3M
Current EBITDA COMPUTED$-8.5M
Operating Margin COMPUTED-4.4%
Occupancy HCRIS42.6%
Revenue / Bed COMPUTED$3.4M
Net-to-Gross HCRIS30.7%
Distress Probability ML47.1%

2. Market Context & Competitive Position

150
WI Hospitals
0.4%
State Median Margin
46
Comparable Hospitals

WI has 150 Medicare-certified hospitals with a median operating margin of 0.4%. The target's margin of -4.4% places it below the state median. Among 46 size-comparable peers (29-116 beds), the median margin is -3.0%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (29-116), prioritizing same-state peers. 46 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MONROE CLINIC (Target)WI58$195.3M-4.4%
ST. JOSEPHS COMM. HOSPT.WI70$436.8M66.1%
MCHS FRANCISCAN HEALTHCARE INWI103$413.8M-7.2%
ST. AGNES HOSPITALWI77$275.9M-3.0%
BELOIT MEMORIAL HOSPITAL INC.WI97$249.6M-3.0%
AURORA MEDICAL CENTER OF OSHKOWI79$222.3M17.9%
MARSHFIELD MEDICAL CENTER-EAU WI56$214.6M-21.8%
AURORA MEDICAL CTR SHEBOYGAN CWI116$211.8M7.7%
ASPIRUS STEVENS POINT HOSPITALWI82$201.4M28.9%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $14.4M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$4.1M+210bp18mo
Cost to Collect4.5%2.5%$3.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$3.9M+198bp12mo
A/R Days Reduction5200.0%3800.0%$2.4M+122bp9mo
Clean Claim Rate88.0%96.0%$125K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$4.1M
Cost to Collect
$3.9M
Denial Rate Reduction
$3.9M
A/R Days Reduction
$2.4M
Clean Claim Rate
$125K
Total EBITDA Uplift$14.4M
Current EBITDA$-8.5M
+ RCM Uplift+$14.4M
Pro Forma EBITDA$5.9M
Current Margin-4.4%
Pro Forma Margin3.0%
WC Released (1x)$7.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-13.1M$87.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-13.1M$92.2M0.00x-100.0%
Bull Case9.0x11.0x$-11.8M$135.4M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-11.8M$144.2M0.00x-100.0%
Bear Case11.0x10.0x$-14.4M$20.0M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-14.4M$17.4M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 46 hospitals with 29-116 beds
  • Same-state prioritization (n=47)
  • Comp margins: P25=-12.7% / P50=-3.0% / P75=15.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.